P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

December 2009

Features

Q&A

An Interview Series with Members of the ASHP Expert Panel on Formulary Management

Part 2: J. Russell May, PharmD

In the second of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
C. Lee Ventola, MS

Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths

Research has addressed individual ADHD drugs, but few head-to-head trials have been conducted. In a meta-analysis of 32 trials, variable drug effects were noted.
Stephen V. Faraone, PhD

Opinion

Comparative Effectiveness Research

Valuable Insight or Government Intrusion?

Comparative effectiveness research has the potential to direct health care spending toward effective therapies and to assist P&T committees. However, some experts question its potential benefit, and others say that collecting the evidence might not be that easy.
F. Randy Vogenberg, RPh, PhD

Commentary

Health Care Blog Watch

Pay-for-Delay and Authorized Generics Back in the Spotlight

Blogs in health care and law are abuzz over a bill to restrict drug companies from “pay-for-delay” patent settlements that postpone the introduction of generics.
Miriam Reisman

Meeting Highlights

American College of Clinical Pharmacy

Parenteral nicardipine for hypertension, omalizumab for asthma, and acquired coagulopathy from the use of topical bovine thrombin are discussed.
Walter Alexander

Pharmaceutical Approval Update

Drugs discussed include ofatumumab, pazopanib, and a C1 esterase inhibitor.
Marvin M. Goldenberg, PhD, RPh, MS

Season’s Greetings: Thanks to Our Reviewers

Departments

Editorial

A Failing Grade

David B. Nash, MD, MBA, discusses the failing grade that Consumers Union (CU), publisher of Consumer Reports, has given to our present health care system — and the CU’s recommendations for reform.
David B. Nash, MD, MBA

Medication Errors

Intravenous Potassium Given Epidurally

Getting to the ‘Route’ of the Problem

Matthew Grissinger, RPh, FASCP, explains how to avoid mixups with intravenous and epidural routes of administration for potassium chloride.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

CMS Changes for Part D Formularies Would Mean More Authority For P&T Committees

Stephen Barlas discusses some proposed changes to Medicare’s Part D program that could make formulary design more flexible and grant more authority to P&T committees.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From Colcrys to Voreloxin, P&T presents the latest studies and information about FDA approvals, drug indications, product recalls, and industry updates.